October 30, 2026

FDA approves tildrakizumab for psoriatic arthritis

The IL-23 inhibitor gains a new indication after 2 phase 3 trials show improved joint responses versus placebo.

MDSpire News

October 30, 2026

FDA revises warnings on 3 estradiol patches

Cardiovascular, breast cancer, and dementia statements are removed, but other risk information remains.

MDSpire News

October 30, 2026

Monthly fasting cycles may be feasible in T2D

Nearly 1 in 3 participants discontinued the yearlong dietary program because of diet-related challenges, despite a 61% completion rate.

MDSpire News

October 30, 2026

Top 10 evidence-based essentials in ObGyn

A structured framework of guidelines, trials, therapies, and tools used in clinical practice.

MDSpire News

October 29, 2026

FDA, CMS target gene therapy barriers

FDA and CMS initiatives aim to simplify gene therapy approvals and expand access to treatments for rare diseases.

MDSpire News

October 29, 2026

The Miniature Spectrometer on Your Wrist

Low-cost optical technology could bring laboratory-level precision to wearable devices for monitoring of blood glucose and other biomarkers

The Pathologist

October 29, 2026

FDA proposes major infant formula update after nearly 30 years

Proposed changes target 4 key nutrients, requesting public input on whether additional ingredients should become mandatory.

MDSpire News

October 29, 2026

Medical Oddities: The ghost that haunted a heart

From haunted hearts to toxic treats, medicine has a few Halloween tricks up its sleeve.

MDSpire News

October 29, 2026

CDC mandates Ebola attestation for US-bound flights

The new requirement applies to US citizens, permanent residents, and foreign travelers.

MDSpire News

October 28, 2026

FDA adds generic valganciclovir oral solution

 The new option is indicated for CMV prophylaxis in pediatric kidney and heart transplant recipients, as well as adult CMV retinitis and transplant prophylaxis.

MDSpire News